申请人:THE CHILDREN'S MEDICAL CENTER CORPORATION
公开号:US11357780B2
公开(公告)日:2022-06-14
The technology described herein is directed to methods of treating lung infections and/or lung inflammation (e.g, pneumonia) by inhibiting IP6K1.
本文所述技术涉及通过抑制 IP6K1 治疗肺部感染和/或肺部炎症(如肺炎)的方法。